1. Home
  2. AMWL vs GBIO Comparison

AMWL vs GBIO Comparison

Compare AMWL & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$4.59

Market Cap

111.4M

Sector

Technology

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.56

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
GBIO
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.4M
36.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AMWL
GBIO
Price
$4.59
$5.56
Analyst Decision
Hold
Buy
Analyst Count
7
5
Target Price
$7.58
$8.88
AVG Volume (30 Days)
137.2K
58.5K
Earning Date
02-11-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$265,023,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.33
N/A
52 Week Low
$3.71
$3.00
52 Week High
$12.95
$12.50

Technical Indicators

Market Signals
Indicator
AMWL
GBIO
Relative Strength Index (RSI) 54.95 56.71
Support Level $4.45 $5.20
Resistance Level $4.82 $5.70
Average True Range (ATR) 0.22 0.23
MACD 0.06 0.04
Stochastic Oscillator 71.28 73.58

Price Performance

Historical Comparison
AMWL
GBIO

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: